Infliximab does not increase colonic cancer risk associated to murine chronic colitis

AIM: To explore the influence of Infliximab (IFX) on cancer progression in a murine model of colonic cancer associated to chronic colitis. METHODS: AOM/DSS model was induced in C57BL/6 mice. Mice were injected with IFX (5 mg/kg) during each DSS cycle while control mice received saline. Body weight,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopetuso, Loris R, Petito, Valentina, Zinicola, Tiziano, Graziani, Cristina, Gerardi, Viviana, Arena, Vincenzo, Caristo, Maria Emiliana, Poscia, Andrea, Cammarota, Giovanni, Papa, Alfredo, Cufino, Valerio, Sgambato, Alessandro, Gasbarrini, Antonio, Scaldaferri, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124977/
https://www.ncbi.nlm.nih.gov/pubmed/27956796
http://dx.doi.org/10.3748/wjg.v22.i44.9727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124977/
https://www.ncbi.nlm.nih.gov/pubmed/27956796
http://dx.doi.org/10.3748/wjg.v22.i44.9727

Ejemplares similares